483 Identi Pharmaceuticals Mar 2017

483 Identi Pharmaceuticals Mar 2017

Nicholas Hunt FDA$595.00 - Available Now

FDA investigators audited the Identi Pharmaceuticals - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 27 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Mar 2017
  • Location: Phoenix, United States
  • FEI: 3012854165
Add To Cart